期刊文献+

Lipid nanomaterials-based RNA therapy and cancer treatment 被引量:3

原文传递
导出
摘要 We summarize the most important advances in RNA delivery and nanomedicine.We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs.The fundamental properties of the key RNA members are described.We introduced recent advances in the nanoparticles to deliver RNA to defined targets,with a focus on lipid nanoparticles(LNPs).We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms,including the treatment of different types of cancer.This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第3期903-915,共13页 药学学报(英文版)
基金 support of the National Key Research and Development Program of China (No.2019YFC1315701) National Natural Science Foundation of China (No.22005343) Cancer Hospital,Chinese Academy of Medical Sciences Shenzhen Center/Shenzhen Cancer Hospital Research Project (No.SZ2020ZD004,China) Shenzhen Science and Technology Program (No.KCXFZ20201221173008022,China) Sanming Project of Medicine in Shenzhen (Nos.SZSM201812062 and SZSM201612097,China) Shenzhen Key Medical Discipline Construction Fund (No.SZXK075,China)
  • 相关文献

同被引文献12

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部